Untitled Document Time Wednesday September 26, 2012 11.30 - 13.00 Registration Chairs: Fredrik Scherstén, Kurt Huber 13.00 - 13.30
Why do we have a symposium on Bleeding Complications.
John W. Eikelboom, McMaster University in Hamilton, Ontario, Canada
13.30 - 14.00
World shortages of blood, new alternative.
Bruce D Spiess, Medical College of Virginia, USA
14.00 - 14.30
Anticoagulation in atrial fibrillation, what´s new.
Tord Juhlin, Skåne University Hospital, Malmö, Sweden
14.30 - 15.00
Managing OAC prior to cardiac interventions.
Peter Svensson, Skåne University Hospital, Malmö, Sweden
15.00 - 15.30 Coffee and Exhibits Chairs: Tord Juhlin, Bruce D Spiess 15.30 - 16.00 NOACs, are they different in terms of effect and bleeding?
Jonas Oldgren, Uppsala University Hospital, Uppsala, Sweden
16.00 - 16.30
Johan Sjögren, Skåne University Hospital, Lund, Sweden
16.30 - 17.00 Refreshments 17.00 - 17.30 Management of massive bleeding.
Pär I Johansson, Rikshospitalet Copenhagen, Denmark
17.30 - 20.00 Get together in the exhibition Time Thursday September 27, 2012 Chairs: Stefan James, Christophe Baufreton 08.30 - 09.00
Modern antiplatelet therapy and CABG, bridging and long term treatment.
David Erlinge, Skåne University Hospital, Lund, Sweden
09.00 - 09.30
Optimal antitrombotic treatment for STEMI.
Sasha Koul, Skåne University Hospital, Lund, Sweden
09.30 - 10.00
10.00 - 10.30 Coffee and Exhibits Chairs: Johan Sjögren, Carsten Metzsch 10.30 - 11.00 Antiplatelet therapy for NSTEMI PCI or medically treated patients.
Peter Clemmensen, Copenhagen University Hospital, Denmark
11.00 - 11.30 Blood transfusions after cardiac surgery; is it the patient or the transfusion that carries the risk?
Alain Dardashti, Skåne University Hospital, Lund, Sweden
11.30 - 12.00 Management of bleeding complications during pediatric heart surgery.
Valeria Perez de Sa, Skåne University Hospital, Lund, Sweden
12.00 – 13.00
Lunch and Exhibits
Chairs: Peter Clemmensen, Anders Jeppsson 13.00 – 13.30
Platelet function testing in ACS.
Christoph Varenhorst, Uppsala University Hospital, Uppsala, Sweden
13.30 – 14.00
Bleeding complications and antithrombotic strategies after TAVI.
Stefan James, Uppsala University Hospital, Uppsala, Sweden
14.00 – 14.30 Trippel therapy, how should one navigate?
Sigrun Halvorsen, Ullevål University Hospital, Oslo, Norway
14.30 – 15.00
Coffee and Exhibits
Chairs: Peter Svensson, Marco Ranucci 15.00 – 15.30 Fibrinogen and bleeding in cardiac surgery patients.
Anders Jeppsson, Sahlgrenska University Hospital, Gothenburg, Sweden
15.30 – 16.00 Perioperative coagulation management in cardiac surgery.
Klaus Görlinger, Tem International GmbH in Munich, Germany
16.00 – 16.30 Low heparin protocols in cardiac surgery - whats new?
Christophe Baufreton, University Hospital of Angers, France
16.30 – 17.00 Refreshments Chair: Jonas Oldgren 17.00 – 17.30 Case presentation.
Lene Holmvang, Copenhagen University Hospital, Copenhagen, Denmark
17.30 – 18.00 Postersession 19.00 – Conference dinner Time Friday September 28, 2012 Chairs: Pär I Johansson, Lene Holmvang 09.00 - 09.30
Transfusion protocols vs early coagulation factor concentrates.
Ulf Schött, Skåne University Hospital, Lund, Sweden
09.30 - 10.00
Pros and cons of whole blood transfusions.
Geir Strandenes, Haukelands University Hospital, Bergen, Norway
10.00 - 10.30
Is there a role for the simple bedside monitor "Platelet works" in patients on platelet inhibitors undergoing PCI/surgery?
Jan van der Linden, Karolinska University Hospital, Stockholm, Sweden
10.30 - 11.00 Coffee and Exhibits Chairs: David Erlinge, John W. Eikelboom 11.00 - 11.30
Anemia and outcome in ACS interventions.
Marco Ranucci, IRCCS Policlinico San Donato, Milano, Italy
11.30 - 12.00
Platelet inhibition in ACS, future perspectives.
Kurt Huber, Wilhelminenspital, Wien, Austria
12.00 - 12.30
Whats next in antithrombotic treatment and bleeding management?
12.30 - Farewell lunch